This February, Walgreens continues their annual spring fundraiser with The Leukemia & Lymphoma Society and Susan G. Komen. During this multi-year partnership, Walgreens pledges to donate more than $25 million by 2024 to advance research for tough-to-treat cancers and increase equitable access to care.
Through online and in-store donations, Walgreens is helping advance research in metastatic breast and pediatric blood cancers and increasing access to treatment and support services for cancer patients.
Donations made at checkout at more than 9,000 U.S. Walgreens locations will be split evenly between the two organizations.
To date, Walgreens donations to LLS have helped accelerate the delivery of cancer treatment to pediatric patients and provided caregivers and survivors with access to financial and emotional resources they need throughout their blood cancer journey.
Funds have also been used to design and launch specialized training courses for Walgreens pharmacists to offer more targeted care and resources for patients battling cancer, and to fund LLS’s Blood Cancer Conferences, which are free education events about treatment options, emerging therapies and managing survivorship.
“Walgreens is a valued and longstanding partner in helping LLS advance blood cancer treatment and provide critical support to patients, caregivers and their families, regardless of their background or economic status,” said Louis J. DeGennaro, Ph.D., President and CEO of The Leukemia & Lymphoma Society (LLS). “Together we work to identify the serious unmet needs of those affected by cancer, with a shared commitment to reducing health disparities. Funds raised through Walgreen’s annual spring checkout campaign not only help us accelerate groundbreaking research that leads to new blood cancer treatments but ensure that more patients in underrepresented communities can access them.”
To participate, find your local Walgreens store here.